The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Electromedical Technologies's Revenue for the
three
months ended in Sep. 2024 was $0.04 Mil. Electromedical Technologies's average Accounts Receivable for the
three
months ended in Sep. 2024 was $0.01 Mil.
Hence, Electromedical Technologies's Receivables Turnover for the
three
months ended in Sep. 2024 was 7.82.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Electromedical Technologies Receivables Turnover Related Terms
Electromedical Technologies Receivables Turnover Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EMED vs DYNT, SONX, USAQ: Receivables Turnover Comparison
For the Medical Devices subindustry, Electromedical Technologies's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Electromedical Technologies Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Electromedical Technologies's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Electromedical Technologies's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Electromedical Technologies (EMED) has a Receivables Turnover of 7.82 as of Sep. 2024. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Electromedical Technologies and its competitors.
Is Electromedical Technologies' Receivables Turnover too high?
Electromedical Technologies' current Receivables Turnover is 7.82. The Medical Devices & Instruments industry median Receivables Turnover is 5.51. Electromedical Technologies' value of 7.82 is 41.9% above this industry median.
How does Electromedical Technologies' Receivables Turnover compare to DYNT and SONX?
Electromedical Technologies' Receivables Turnover of 7.82 can be compared against companies in the Medical Devices & Instruments industry. The industry median Receivables Turnover is 5.51. Electromedical Technologies' value of 7.82 is 41.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.51, based on 811 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Electromedical Technologies's current Receivables Turnover of 7.82 is 41.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Electromedical Technologies and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Electromedical Technologies's current Receivables Turnover is 7.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Electromedical Technologies stock overvalued right now?
Electromedical Technologies (EMED) has a current Receivables Turnover of 7.82. The current Receivables Turnover is 7.82 and 41.9% above the Medical Devices & Instruments industry median of 5.51. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Electromedical Technologies (EMED), the current Receivables Turnover is 7.82 as of Sep. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Electromedical Technologies Inc is a Delaware-based bioelectronics manufacturing company. The company designs, develops, and markets FDA-cleared, non-invasive, and simple-to-use bioelectronics therapy medical devices that serve as drug-free alternatives for pain relief. The company's device provide immediate and long-lasting pain relief across the broadest range of ailments. It focuses on improving globalised wellness for people suffering from various painful conditions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EMED has been successfully added to your 